Section
Depression, anxiety, trauma, substance use, dementia and emerging treatments, as reported by clinical and research outlets.
846 articles · page 5 of 22 · Apr 24, 2026 – May 4, 2026
Archive summary Clinical
Tennessee is moving forward with clinical trials of ibogaine, a controversial psychedelic drug recently fast-tracked for research by the Trump administration.
Archive summary Clinical
Axsome Therapeutics (NASDAQ:AXSM) announced that the U.S. Food and Drug Administration has approved Auvelity for the treatment of agitation associated with dementia due…
Archive summary Clinical
The U.S. Food and Drug Administration (FDA) on Thursday approved Axsome Therapeutics Inc.'s (NASDAQ: AXSM ) Auvelity (dextromethorphan HBr and bupropion HCl) for…
Archive summary Clinical
Step Denver, a low-cost recovery program for men, has lowered its minimum entry age from 21 to 18, reflecting a shift in how the organization approaches early…
Archive summary Clinical
The first Phase 3 clinical trial of psilocybin for treatment-resistant depression has met its primary endpoint, marking a significant milestone for psychedelic…
Archive summary Clinical
Kratom is “highly addictive even for people who aren’t addicts,” said Dr. Joe Desanto. “It’s an evil drug. I’m scared for the general public.”
Archive summary Clinical
Archive summary Clinical
Several million people are addicted to methamphetamines and also use tobacco, cannabis, alcohol, benzos, and opioids. Treatment is challenging. Mirtazapine could help.
Archive summary Clinical
The Trump administration released a 195-page national drug control strategy proposing novel surveillance methods, artificial intelligence applications, and expanded…
Archive summary Clinical
(NaturalNews) A new study from researchers at APC Microbiome Ireland at University College Cork has found that regular coffee consumption is associated with measura...
Archive summary Clinical
Archive summary Clinical
Archive summary Clinical
When Hurricane Helene ripped through western North Carolina in late September 2024, residents faced not only infrastructure damage but an urgent public health crisis for…
Archive summary Clinical
Archive summary Clinical
Imperial County Behavioral Health Services (ICBHS) celebrated the groundbreaking of a new adult residential substance use disorder treatment facility on Thursday,…
Archive summary Clinical
No Matter What Recovery opened a new outpatient treatment facility on Chicago's North Side near the corner of Halsted and Belmont, addressing addiction and what health…
Archive summary Clinical
AUVELITY is a first-in-class treatment, which targets the NMDA and sigma-1 receptors, approved for agitation associated with dementia due to Alzheimer's disease The…
Archive summary Clinical
AUVELITY is a first-in-class treatment, which targets the NMDA and sigma-1 receptors, approved for agitation associated with dementia due to Alzheimer’s disease
Archive summary Clinical
Health and Human Services Secretary Robert F. Kennedy Jr. is championing San Patrignano, a drug treatment community in rural Italy east of Florence, as a model for U.S.…
Archive summary Clinical
The Supreme Court rejected a nationwide settlement with OxyContin maker Purdue Pharma that would have shielded members of the Sackler family who own the company from…
Archive summary Clinical
Monroe County received new funding to secure 24/7 operations at Delphi Rise, the county's only open-access clinic dedicated to substance use disorder support. On…
Archive summary Clinical
Federal initiatives focused on PTSD and related conditions appears to validate need for new and novel approaches to mental health treatment
Archive summary Clinical
The global addiction treatment market is experiencing rapid expansion, with the sector valued at USD 6.4 billion in 2025 and projected to reach USD 11.6 billion by 2036,…
Archive summary Clinical
The federal government has paid to supply the test strips, which also check for other contaminants, to states since 2021, but the Trump administration now contends that…
Archive summary Clinical
Health Secretary Robert F. Kennedy Jr. has proposed building a national system of "wellness farms" for addiction treatment, citing an Italian rural community as a model.…
Archive summary Clinical
(NaturalNews) The FDA announced accelerated review for three companies studying psilocybin and methylone as treatments for depression and PTSD. President Tru...
Archive summary Clinical
Natural disasters create severe disruptions for people in recovery from opioid addiction, threatening access to medication and triggering relapses. After Hurricane…
Archive summary Clinical
AtaiBeckley Inc. announced positive Phase 2a results for BPL-003, an intranasal treatment for treatment-resistant depression (TRD). The study found that 66.7% of…
Archive summary Clinical
Britney Spears, 44, has voluntarily entered a substance abuse treatment facility just over a month after her arrest on suspicion of driving under the influence. On March…
Archive summary Clinical
A revolutionary depression treatment now available at Medical University of South Carolina delivers relief in days rather than months, offering hope for patients with…
Archive summary Clinical
AtaiBeckley Inc. presented promising clinical data on BPL-003 for treatment-resistant depression at the American College of Neuropsychopharmacology annual meeting, with…
Archive summary Clinical
Nitazenes, a class of synthetic opioids originally created in the 1950s but never approved for medical use, are emerging as a significant public health threat. Also…
Archive summary Clinical
Archive summary Clinical
The FDA's Marty Makary fast-tracked research for three companies to make psychedelic treatments for mental illness.
Archive summary Clinical
Erika Edwards is a health and medical news writer and reporter for NBC News and 'TODAY.'
Archive summary Clinical
Psilocybin, the active ingredient in magic mushrooms, is moving into the mainstream.
Archive summary Clinical
A weekly roundup of policy news in the chemical arena and beyond
Archive summary Clinical
A 42-year-old was scheduled for a hysterectomy after decades of chronic pain. Then, a chance encounter led to a life-changing discovery.
Archive summary Clinical
If scheduled to a less high-risk classification, the result would expand opportunities from the growing cannabis industry and its medical usage.
Archive summary Clinical
(NaturalNews) Introduction: The Empowering News for a Brighter MoodFor anyone who's ever felt their mood dip and instinctively known their food could be part of t...